Notably, under CDDP treatment, the combined application of the SIRT7 shRNA and EZH2 shRNA lentiviruses markedly enhanced the tumor RND3 protein levels compared to the administration of either shRNA lentivirus alone (Fig. 9D). This evidence concerns the gene EZH2 and neoplasm.